FDA Drug recall D-1861-2019
Soothing Sore Relief (lidocaine) Liquid Gel, 4%, packaged in a) 1 Oz (NDC 69804-077-14), b) 2 Oz (NDC 69804-077-15), and c) 4 Oz (NDC 69804…
- FDA Drug
- Class II
- terminated
- Published 2019-09-25
On 2019-09-25 the FDA classified a Class II recall of Soothing Sore Relief (lidocaine) Liquid Gel, 4%, packaged in a) 1 Oz (NDC 69804-077-14), b) 2 Oz (NDC 69804-077-15), and c) 4 Oz (NDC 69804… by Ridge Properties, citing superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1861-2019 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-08-09 |
| Published | 2019-09-25 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Ridge Properties |
| Distribution | US |
Product
Soothing Sore Relief (lidocaine) Liquid Gel, 4%, packaged in a) 1 Oz (NDC 69804-077-14), b) 2 Oz (NDC 69804-077-15), and c) 4 Oz (NDC 69804-077-16) bottles, OTC, Manufactured, packed & distributed by Pain Relief Naturally, Salem, OR 97301.
Reason
Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Identifiers
| code_info | Lot # 1135, Exp 12/27/2022 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1861-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.